Third-party reimbursement for generic prescription drugs: The prevalence of below-cost reimbursement in an environment of maximum allowable cost–based reimbursement

Overview of attention for article published in Journal of the American Pharmaceutical Association, May 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (60th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Readers on

mendeley: 25 Mendeley

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 7,015 followers.

@runbrownie1 @AndreskiMike @IowaPharmacyIPA This is great, Seth! Thanks @AndreskiMike for this important work. A 2018 study we conducted using a rural pharmacy’s dispensing data found that one private payer was reimbursing the pharmacy below acquisition c…

@jordan_ballou 2/2 Hard to say "PBM caused this." Couple of additional resources that might contribute to the discussion and highlight some scientific literature used in the PBM discussion: https://t.co/mLBMrcYoVl Rutledge vs. PCMA: https://t.co/f2sSS…

Third-party reimbursement for generic prescription drugs: The prevalence of below-cost reimbursement in an environment of maximum allowable cost-based reimbursement - PubMed https://t.co/vYTEJPcmV7

RT @unc_cmopp: Pharmacies paid less than cost for many generics study in @ELSpharma reveals. Reimbursement often below cost to #pharmacy: 1…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.